Chapter 508 Sole Agent

What's more, Jing Xiaoran is already preparing his own pharmaceutical factory.

With the help of Weng Huijin, the work of the pharmaceutical factory is nearing completion. As long as the Shenzhou laboratory passes the GCP review, the pharmaceutical factory can start construction at any time.

Reject half a billion dollars!

This was a difficult decision, but after thinking twice, Jing Xiaoran gritted his teeth and refused.

I saw that Hamer looked quite hesitant, and wanted to open his mouth, but swallowed the words back.

Jing Xiaoran was really afraid that a number, even more unbearable, would come out of his mouth.

"Mr. Hammer, please stop talking about it." Jing Xiaoran said hastily, "I will not transfer patents for immune checkpoint inhibitors. I am different now than I was four years ago!"

Four years ago, he urgently needed a sum of money.

Now he has more important goals.

"Hey." Hamer sighed slightly.

[-] million US dollars, in fact, has not yet reached the upper limit of Pfizer's heart.

But Jing Xiaoran's attitude has already been decided, and Hammer is not very good to continue talking.

"Jing, since you are unwilling to resell the patent of immune checkpoint inhibitors to us Pfizer, then you have made such a few detours and told us the news of the successful development of the Shenzhou laboratory. What is the purpose?"

Hamer knew in his heart that Jing Xiaoran mainly sent emails to him, and he must have something to discuss with him, and he would not aim at nothing.

And this matter definitely involves the cooperation of both parties.

Jing Xiaoran coughed lightly, sorted out the thoughts in his mind, and said softly: "Hammer, although our Shenzhou Laboratory cannot resell patents, there is another way of cooperation."

Hammer put away his depressed mood and stared at Jing Xiaoran curiously, "What method?"

"Agency!"

As soon as Jing Xiaoran finished these words, Hamer understood what he meant.

"Do you want to hand over the agency qualification of immune checkpoint inhibitors in the United States to Pfizer?"

Jing Xiaoran nodded, "Yes, I don't know what Mr. Hammer wants?"

"Agency?" Hammer mused, "This is indeed a way."

If you want to resist Pfizer's decline in the oncology field in a short period of time, it seems that the best way is to act as an agent for a very promising drug.

The immune checkpoint inhibitors of Shenzhou Laboratories just fit this feature.

The most important thing is that Shenzhou Lab really needs an agent to help expand its business in the United States and China.

After careful consideration, Hammer accepted Jing Xiaoran's proposal and obtained the exclusive agent of immune checkpoint inhibitors.

"However, this price is not as high as the patent transfer fee." Hamer said.

"Of course I know this." Jing Xiaoran nodded, "Hammer, then I will hand over the agency rights of immune checkpoint inhibitors in the United States to you Pfizer!"

Hammer knocked the corner of his mouth slightly to death.

This time I came to Huaxia, and I finally did not return empty-handed!

"However, Hammer, if our immune checkpoint inhibitors want to obtain a production license in the United States, we need to pass the US FDA certification." Jing Xiaoran continued, "So this matter may have to trouble Pfizer."

After finishing speaking, Jing Xiaoran glanced at Hamer.

Let Pfizer help pass the FDA certification, this is Jing Xiaoran's ultimate goal!

"That's easy to say, easy to say!" Hammer responded indifferently.

For Pfizer, if any of its drugs wants to pass the FDA, it is as simple as eating and drinking.

"In the United States, as long as we, Pfizer, want to market drugs, they have not failed so far." Hammer laughed, "Leave this matter to me!"

What Hammer never imagined was that the Shenzhou Laboratory had completed all the basic and clinical research and development work, but was stopped by a Chinese GCP!

……

Next, Jing Xiaoran took Hamer to visit the immune checkpoint inhibitor laboratory of Shenzhou Experiment.

This also means that Shenzhou Laboratory and Pfizer have reached a preliminary cooperation.

Although Pfizer cannot obtain complete drug patent rights, it can also make a lot of money with an agent qualification!
As for Jing Xiaoran, he not only solved the current dilemma of immune checkpoint inhibitors, but also got a sum of money from Pfizer to alleviate the current shortage of funds in Shenzhou Lab!
After Hammer returned to the United States, he began to work non-stop for the immune checkpoint inhibitors of Shenzhou Laboratory!
With the authorization of Pfizer's top board of directors, Hamer can mobilize all resources and pave the way for immune checkpoint inhibitors.

After all, no one will have trouble with money!

If the immune checkpoint inhibitor of Shenzhou Laboratory can pass the FDA certification in the first time and successfully suppress AstraZeneca, this will not only benefit Pfizer now, but also facilitate the entire long-term development!

Therefore, after obtaining the relevant information from the Shenzhou laboratory, Hamer began to lobby the FDA review committee.

As one of the largest pharmaceutical companies in the world, almost no one can prevent Shenzhou Laboratories from passing FDA certification!

……

After a month.

Shenzhou Laboratory.

The atmosphere in the laboratory is a bit oppressive now, especially the entire immune checkpoint inhibitor experimental group.

Everyone's heart seems to be pressed by a big stone!

Huaxia GCP has not passed the review for a long time, and everyone doesn't want to eat or drink!

Zhu Xianqing has been paying attention to the news from Huaxia GCP every day, and found that the review progress of this immune checkpoint inhibitor is extremely slow!

He tried to communicate with relevant GCP personnel many times, but there was no response.

Zhu Xianqing also realized that someone was making trouble.

And this person's rights are not small.

"Xiao Ran, I don't think you're in a hurry at all."

When he came to Jing Xiaoran's office, Zhu Xianqing found that he was editing someone else's paper.

"Mr. Zhu, this matter can't be rushed." Zhu Xianqing was holding a paper and carefully correcting the mistakes in it.

"But now it's been almost two months since we applied for GCP review!" Zhu Xianqing said anxiously, "Even according to the normal procedures, we have already got preliminary results, but there is no news from GCP at the moment! "

"Every time I go to GCP to inquire, the staff tells me to come back and wait!"

"Wait! Wait! Wait! If AstraZeneca's experiment works, then we're done!"

Jing Xiaoran took a deep breath, and then let it out slowly.

He looked at Zhu Xianqing and said, "Teacher Zhu, don't worry. It's almost there, it should be soon!"

"What's coming soon?" Zhu Xianqing asked doubtfully.

Jing Xiaoran smiled slightly, but did not speak.

"Xiao Ran, you mean GCP review?"

Jing Xiaoran shook his head.

"What is that?" Zhu Xianqing frowned.

Jing Xiaoran said indifferently: "FDA review!"

"FDA?" Zhu Xianqing was astonished. "It's from the United States. If it's going to be listed in China, it needs to be reviewed by GCP. Wait... let me think..."

Seeing the smile on Jing Xiaoran's face, Zhu Xianqing's eyes lit up.

(End of this chapter)

Tap the screen to use advanced tools Tip: You can use left and right keyboard keys to browse between chapters.

You'll Also Like